Vimarsana
Biggest News Aggregation in the World

Page 33 - Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contract Development Today - Breaking & Trending Today

Antibody Production Companies: Re-shaping Life Sciences Together - Vimarsana News

Antibody Production Companies: Re-shaping Life Sciences Together

Antibody production companies are essential in dealing with the growing demand for antibodies for life sciences, therapeutic, and diagnostic applications. Therefore, a number of service providers are specialized in offering various types of services regarding the complex production of antibodies.

Vetter Joins Science Based Targets Initiative (SBTi) - Vimarsana News

Vetter Joins Science Based Targets Initiative (SBTi)

Vetter, a leading globally operating Contract Development and Manufacturing Organization (CDMO), has joined the Science Based Targets Initiative (SBTi) membership group as of November 2023. The goal of the companies in the SBTi is to achieve climate neutrality by 2050, thus representing the strictest climate ...

My Green Lab Unveils Converge, a Collaborative Supply Chain Initiative ... - Vimarsana News

My Green Lab Unveils Converge, a Collaborative Supply Chain Initiative ...

My Green Lab Unveils Converge, a Collaborative Supply Chain Initiative ...

Piramal Pharma allocates Rs 330 crore towards capex H2FY24 - Vimarsana News

Piramal Pharma allocates Rs 330 crore towards capex H2FY24

Firm targets Rs 1,000 crore growth in consumer health business

Unither Pharmaceuticals celebrates 30 years of innovation and expertise - Vimarsana News

Unither Pharmaceuticals celebrates 30 years of innovation and expertise

Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pharmaceutical plant that produced 3